News

U.S. stock futures on Friday traded in a tight range around record-high levels, after what's been a mostly positive week for second-quarter earnings and for macroeconomic data. Dow Jones Industrial Av ...
A downbeat earnings report, plus investor disdain for the pending Cox Communications merger, is sending the stock to a ...
The U.S. bond market was broadly rising Friday afternoon as Treasury yields retreated. The iShares Core U.S. Aggregate Bond ETF and the Vanguard Total Bond Market ETF, which both broadly track the U.S ...
PayPal’s stock is on track to rise for the eighth session in a row, but analysts have a hard time making a call about the ...
The Social Security Administration quietly corrected a blog post that had asserted that the recent federal budget bill ...
The stock market's momentum still has room to run if macroeconomic conditions improve, or even stabilize, as the S&P 500 attempts a fifth straight record closing high, according to Mark Hackett, chief ...
Most of the S&P 500’s sectors were trading higher Friday afternoon, with the widely followed U.S. stock-market index on course to close out the week with a fifth-straight record closing high.
Shares of Gencor Industries climbed after the heavy machinery manufacturer logged higher sales in its first quarter. The stock rose 10%, to $15.85, midday Friday. Shares have declined 10% year to date ...
Shares of Genworth Financial rose Friday after a U.K. court ruling in a payment protection insurance case that could lead to a $750 million windfall for the company. The stock of the Richmond, ...
An exchange-traded fund that buys stocks in Europe was paring losses after the head of the European Commission indicated a positive development in trade discussions with the U.S. The iShares MSCI ...
Natural-gas futures were poised Friday to end the week with a loss of 13%, their largest such decline since January. Expectations for higher U.S. production this year — with the number of active U.S.
Shoulder Innovations has filed for an initial public offering worth up to $105 million. The commercial-stage medical-technology company said it will sell 5 million shares at $19 to $21 apiece, ...